Carregant...
NeutrobodyPlex—monitoring SARS‐CoV‐2 neutralizing immune responses using nanobodies
In light of the COVID‐19 pandemic, there is an ongoing need for diagnostic tools to monitor the immune status of large patient cohorts and the effectiveness of vaccination campaigns. Here, we present 11 unique nanobodies (Nbs) specific for the SARS‐CoV‐2 spike receptor‐binding domain (RBD), of which...
Guardat en:
| Publicat a: | EMBO Rep |
|---|---|
| Autors principals: | , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley and Sons Inc.
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8097376/ https://ncbi.nlm.nih.gov/pubmed/33904225 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embr.202052325 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|